Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
October 22, 2001
- Abbereviationon of the week
October 22, 2001
- Not to Expect Gov't to Adopt ATP Soon: Mr Butler of PhRMA -1-
October 22, 2001
- Benefits of INNOVA2000 Explained: GE Yokogawa Seminar
October 22, 2001
- Not to Expect Gov't to Adopt ATP Soon: Mr Butler of PhRMA -2-
October 22, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 22, 2001
- Mitsubishi Pharma Establishes Subsidiaries in US, UK
October 22, 2001
- Industry Expresses Opinions on Pricing of Medical Devices: Chuikyo
October 22, 2001
- Losses Reported by 19 of 93 FJPWA Member Wholesalers
October 22, 2001
- GE Marquette Medical Systems: Ultra-small ECG Recorder "SEER Light"
October 22, 2001
- BUSINESS NEWS IN BRIEF -1-
October 22, 2001
- Hac Kimisawa: Half-year Ordinary Profits Up 13.8%
October 22, 2001
- BUSINESS NEWS IN BRIEF -2-
October 22, 2001
- Sugi Yakkyoku: Sales, Profits Up Over 30% in First Half
October 22, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
October 22, 2001
- OTC NEW IN BRIEF
October 22, 2001
- NOTICE
October 22, 2001
- Usefulness of Aspirin Underlined: Dr Hennekens
October 22, 2001
- NHI Price Ceiling to Be Set: Reform Proposal -1-
October 22, 2001
- DIAGNOSTIC NEWS IN BRIEF
October 22, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…